Advertisement

Related Videos

Deborah Collyar: What's In It for Patients?

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Advertisement

Advertisement




Mar
19
Today In Oncology
Timely Scans May Reduce Mortality in Patients Who Present to the ER With Hematuria
PSMA PET-CT Scan Reduces Need for Prostate Cancer Biopsies
New AACR President-Elect and Board Members Announced
Activity Observed With Novel KRAS Inhibitor in Pancreatic Cancer (1)
Neoadjuvant/Adjuvant Doublet Significantly Improved Survival in Patients With Muscle-Invasive Bladder Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo